MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-KR-03-0095161
Ameliorate Biotech Private Limited - life sciences in Bangalore, Karnataka, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹22.31 Lakh
▼ 29% YoY
Net loss · FY 2025
₹61.28 Lakh
Net margin -274.7%
EBITDA · FY 2025
-₹53.7 Lakh
EBITDA margin -240.7%
Authorised capital
₹12 Lakh
Registered with MCA
Paid-up capital
₹8.61 Lakh
Issued & subscribed
Company age
11 yrs
Est. 2015
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered
About Ameliorate Biotech Private Limited
Data last updated:
Ameliorate Biotech Private Limited is a private limited company based in Bangalore, Karnataka, India. It operates in the biotechnology segment of the life sciences sector. It was incorporated on 20 October 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U74900KA2015PTC083551. Its GSTIN is 29AANCA8603K1Z7 (Karnataka).
The company has an authorised share capital of ₹12 Lakh and a paid-up capital of ₹8.61 Lakh. It is led by directors Rashbehari Tunga and Binita Shrivastava Tunga.
Its last annual general meeting (AGM) was held on 27 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Bangalore, Karnataka.
As per the financials filed for FY 2025, the company reported a revenue of ₹22.31 Lakh, a decline of 29% compared to the previous year. For the same year it recorded a net loss of ₹61.28 Lakh (net margin -274.7%) and EBITDA of -₹53.7 Lakh (EBITDA margin -240.7%). Revenue has grown at a compounded annual rate (CAGR) of 18% over five years.
The company is associated with 1 brand: Ameliorate Biotech. The company has 9 deals on record (5 secondary share transfers, 3 funding rounds, 1 rights issue), with disclosed funding of ₹2.31 Cr; the latest was in June 2020. Its 3 peer companies in the Biotechnology industry (Biotechnology), with the same principal business activity (scientific research and development) are compared by revenue, 3 smaller; the largest is Kanashi Biotech Private Limited with revenue of ₹21.92 Lakh.
Ameliorate Biotech Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-KR-03-0095161). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website amelioratebiotech.com.
Company details
CIN U74900KA2015PTC083551
Registration Number 083551
Incorporation Date 20 October 2015
ROC Bangalore
Listing Status Unlisted
Company Status Active
Date of Last AGM 27 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-KR-03-0095161
Recognitions & Rankings of Ameliorate Biotech
Contact details
Ameliorate Biotech Private Limited's registered office is in Bangalore, Karnataka. Its website is amelioratebiotech.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressAtal Incubation Centre Jyothi Institution Of Technology Foundat, Ion, Bangalore, Karnataka, India – 560062
- IndustryLife Sciences, Biotechnology
To see the full contact details of Ameliorate Biotech Private Limited, buy the company report.
Comprehensive company report
Ameliorate Biotech Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Ameliorate Biotech operates one associated brand: Ameliorate Biotech. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Developer of recombinant therapeutic proteins and diagnostic kits | amelioratebiotech.com |
Financials of Ameliorate Biotech Private Limited
FY 2025 filings availableAmeliorate Biotech Private Limited reported revenue of ₹22.31 Lakh (down 29% YoY) for FY 2025.
Revenue · FY 2025
₹22.31 Lakh ▼ 29%
Net loss · FY 2025
₹61.28 Lakh margin -274.7%
EBITDA · FY 2025
-₹53.7 Lakh margin -240.7%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 29%
5 years · compounded
▲ 18%
EBITDA CAGR growth
1 year
▲ 39%
3 years · compounded
▲ 3%
5 years · compounded
▼ 19%
Revenue fell 29% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 18%. EBITDA rose 39% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹53.7 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹61.28 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -240.7% | ||||
| Net Profit Margin | -274.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Ameliorate Biotech Private Limited, buy the company report.
Board of directors of Ameliorate Biotech Private Limited
Ameliorate Biotech has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rashbehari Tunga | Director | 20 Oct 2015 | 11 Years 0 Months | Current |
| Binita Shrivastava Tunga | Director | 20 Oct 2015 | 11 Years 0 Months | Current |
Peer comparison
Ameliorate Biotech Private Limited is compared with the 3 companies closest to it by revenue in the Biotechnology industry (Biotechnology), with the same principal business activity (scientific research and development), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Ameliorate Biotech Private Limitedthis company | ₹22.31 Lakh (FY 2025) | -₹61.28 Lakh | -274.7% | -29.0% | Bangalore, Karnataka, India | |
| Kanashi Biotech Private Limited | ₹21.92 Lakh (FY 2025) | 38.0% | Pune, Maharashtra, India | |||
| Aerobic Biotaxy India Private Limited | ₹21.6 Lakh (FY 2020) | -76.0% | Bangalore, Karnataka, India | |||
| Kbcols Sciences Private Limited | ₹21.53 Lakh (FY 2025) | -89.0% | Dombivli, Maharashtra, India |
To see the full peer comparison of Ameliorate Biotech Private Limited, buy the company report.
Auditor
Ameliorate Biotech Private Limited is audited by R S T & CO for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| R S T & CO | FY 2023 | 013239S |
Shareholding
The shareholding of Ameliorate Biotech Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Ameliorate Biotech Private Limited, buy the company report.
Deals & funding
Ameliorate Biotech Private Limited has 9 deals on record (5 secondary share transfers, 3 funding rounds, 1 rights issue), with disclosed funding of ₹2.31 Cr; the latest was in June 2020.
Total deals
9
Secondary share transfers
5
Funding rounds
3
Rights issue
1
Disclosed funding
₹2.31 Cr
Deals on record (5 of 9)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Jan 2020 | Rights issue | ₹5 Lakh | Investors: an individual |
| Nov 2019 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: 3 individuals |
| May 2019 | Funding round | ₹6 Lakh | Investors: 2 individuals |
| Feb 2018 | Secondary share transfer | Undisclosed | Buyer: 3 individuals Seller: 2 individuals |
| Jan 2018 | Funding round | ₹5 Lakh | Investors: 2 individuals |
To see the full deal history of Ameliorate Biotech Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
No court or tribunal cases involving Ameliorate Biotech Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Ameliorate Biotech Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Ameliorate Biotech has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29AANCA8603K1Z7 | Karnataka | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Ameliorate Biotech Private Limited, buy the company report.
Recent activity
Ameliorate Biotech Private Limited has 5 board changes on record since 2015: 2 appointments and 3 cessations. The latest: Atul Srivastava ceased to be Director on 01 Aug 2016.
AGM
Ameliorate Biotech Private Limited last Annual general meeting of members was held on 27 Sep 2025 as per latest MCA records.
Filing
Ameliorate Biotech Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Bangalore.
Ceased
Atul Srivastava ceased to be Director.
Ceased
Sunil Shekar Koppa Somashekara ceased to be Director.
Ceased
Vasanth Samaga ceased to be Director.
Appointed
Binita Shrivastava Tunga was appointed as Director.
Appointed
Rashbehari Tunga was appointed as Director.
Incorporation
20 Oct 2015
Ameliorate Biotech Private Limited was registered on 20 Oct 2015 with Roc Bangalore & aged 11 years 7 days as per MCA records.
Frequently asked questions
Ameliorate Biotech is an active private limited company based in Bangalore, Karnataka, India. The company works in biotechnology, within the life sciences industry. It was incorporated on 20 October 2015 (11+ years old) and is registered under CIN U74900KA2015PTC083551.
Ameliorate Biotech has 2 current directors:
- Rashbehari Tunga - Director
- Binita Shrivastava Tunga - Director
The latest financial statements of Ameliorate Biotech on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 27 September 2025. Year-wise statements from FY 2016 are in the company report.
The GSTIN of Ameliorate Biotech is 29AANCA8603K1Z7, registered in Karnataka.
The CIN (Corporate Identification Number) of Ameliorate Biotech is U74900KA2015PTC083551. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Ameliorate Biotech was incorporated on 20 October 2015, making it 11+ years old. It is registered with the Registrar of Companies, Bangalore.
Ameliorate Biotech has 9 deals on record (5 secondary share transfers, 3 funding rounds, 1 rights issue), with disclosed funding of ₹2.31 Cr; the latest was in June 2020.
The peers of Ameliorate Biotech by revenue are Kanashi Biotech Private Limited, Aerobic Biotaxy India Private Limited, Kbcols Sciences Private Limited, all in the Biotechnology industry (Biotechnology), with the same principal business activity (scientific research and development).
Atul Srivastava ceased to be Director on 01 Aug 2016. Sunil Shekar Koppa Somashekara ceased to be Director on 21 Mar 2016. Vasanth Samaga ceased to be Director on 25 Feb 2016. Ameliorate Biotech has 5 board changes on record in total.
Yes, Ameliorate Biotech is registered as a micro enterprise under Udyam registration (number: UDYAM-KR-03-0095161).
Ameliorate Biotech can be reached through the website amelioratebiotech.com. Its registered office is in Bangalore, Karnataka, India.